MedPath

Effect of Dihydrocapsiate on Energy Expenditure in Women

Not Applicable
Completed
Conditions
Obesity
Interventions
Dietary Supplement: Dihydrocapsiate
Registration Number
NCT01773356
Lead Sponsor
Ellen Evans
Brief Summary

The objective of this study is to test the effect of dihydrocapsiate on energy expenditure in women.

Detailed Description

Capsaicin, a substance found in chili pepper, is known to stimulate thermogenesis. Dihydrocapsiate, a capsinoid, found in the non-pungent CH-19 sweet pepper has similar thermogenic effects without the gastrointestinal side effects. The objective of this project is to test the effect of 12 weeks of daily consumption of 9 mg dihydrocapsiate on resting energy expenditure relative to baseline when compared to a control group consuming products without DCT.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
126
Inclusion Criteria
  • BMI: 18.5-34.5 kg/m2
  • Good general health
  • Low to mild physical activity
  • Willing to maintain habitual diet and physical activity patterns throughout the study period
  • Premenopausal and cycling regularly or using oral contraceptives
  • Willing to attend study visits only during the follicular phase or bleed phase of their menstrual cycle
  • Understands study procedures and signs forms providing informed consent to participate in the study
  • Have spoken and written English literacy
Exclusion Criteria
  • Diabetes mellitus or any conditions that might affect energy metabolism
  • Weight change ±2 kg over previous three months
  • Known sensitivity or allergy to ingredients of the study products
  • Non-breakfast eater
  • Recent use of antibiotics
  • History of smoking during the six months prior to study
  • Recent signs or symptoms of infection, including cold or flu-like symptoms
  • Concurrent or recent intervention study participation
  • Instability in breathing patterns or energy expenditure measures
  • History of drug or alcohol abuse
  • Lipid-lowering, anti-hypertensive or anti-inflammatory steroid medication use
  • Weight loss medication
  • Pregnant or lactating
  • Unwilling to be randomized to any experimental group and unable to meet all requirements of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dihydrocapsiate 9 mg/dDihydrocapsiate9 mg/d of Dihydrocapsiate will be consumed in ready to ear cereal, cereal bars or crackers
Placebo 0 mg/dDihydrocapsiate0 mg/d of Dihydrocapsiate will be consumed in ready to ear cereal, cereal bars or crackers
Primary Outcome Measures
NameTimeMethod
Resting Energy ExpenditureChange from Baseline at 12 weeks
Secondary Outcome Measures
NameTimeMethod
Thermic effect of feedingChange from baseline at 12 weeks
Body CompositionChange from baseline at 12 weeks

Trial Locations

Locations (1)

University of Georgia, Department of Kinesiology

🇺🇸

Athens, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath